Imidazo[1,2-a]pyridine derivatives for the treatment of silent gastro-esophageal reflux

A gastroesophageal reflux and drug technology, applied in the direction of drug combinations, organic active ingredients, medical preparations containing active ingredients, etc.

Inactive Publication Date: 2009-02-11
ASTRAZENECA AB
View PDF48 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, a patient may tell a doctor that they have a sleep disturbance but do not have GERD symptoms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Imidazo[1,2-a]pyridine derivatives for the treatment of silent gastro-esophageal reflux
  • Imidazo[1,2-a]pyridine derivatives for the treatment of silent gastro-esophageal reflux

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0172] Medical history and physical examination were performed on subjects meeting the inclusion criteria. All subjects will undergo standard drug screening tests. Subjects will complete the Pittsburgh Sleep Quality Index, the Functional Outcomes of Sleep Questionnaire, the Beck Depression Inventory, and the SF-36 to assess quality of life. All subjects will complete daily sleep records for two weeks. At the end of this "pilot" period, nighttime disturbance and early morning depression assessments will be conducted. After characterization, all subjects underwent comprehensive polysomnography (PSG) to measure esophageal pH. All subjects completed the questionnaire before going to sleep and after waking up in the morning. The questionnaire was designed to assess activity and mental status on the day preceding the sleep trial, to assess morning mental status, and subjective statements of wakefulness and heartburn symptoms experienced during the sleep trial.

[0173] The patie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a new method of treatment of sleep disturbance due to silent gastro-esophageal reflux. In particular, the present invention relates to the use of certain imidazo (1,2-a)pyridines derivatives (I) in said treatment.

Description

[0001] This application is a Chinese patent application with the invention creation title of "Imidazolo[1,2-a]pyridine derivatives for the treatment of hidden gastroesophageal reflux" filed on November 3, 2004 (national application number is No. 200480032415.1, a divisional application with international application number PCT / SE2004 / 001589). technical field [0002] The present invention relates to new methods of treating sleep disturbances caused by silent gastroesophageal reflux. In particular, the invention relates to the use of specific imidazo[1,2-a]pyridine derivatives in said therapy. Background technique [0003] Recurrent episodes of reflux symptoms have been shown to have a negative impact on sleep quality. Patients with both upright and supine reflux (day and night) had more esophageal mucosal damage than those with upright (day) reflux. Reduced salivation during sleep, decreased swallowing frequency, and delayed esophageal clearance time contributed to this de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/437A61P1/04
CPCA61K31/437A61P1/00A61P1/04
Inventor P·费恩斯特伦G·哈泽尔格伦
Owner ASTRAZENECA AB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products